Biopsy principles in orthopedics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{SI}} | {{SI}} | ||
{{CMG}}; {{AE}} {{Rohan}} | [[Biopsy|{{CMG}}]][[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]]<span> </span>[mailto:charlesmichaelgibson@gmail.com]; {{AE}} {{Rohan}} | ||
{{SK}} Bone biopsy, Soft tissue biopsy, Biopsy in musculoskeletal system | [[Biopsy|{{SK}} Bone biopsy, Soft tissue biopsy, Biopsy in musculoskeletal system]] | ||
== Overview == | == [[Biopsy|Overview]] == | ||
Biopsy is the gold standard test for the diagnosis of bone and soft tissue tumors. The tumor is then staged based on Enneking system for for benign and malignant bone tumors. | [[Biopsy|Biopsy is the gold standard test for the diagnosis of bone and soft tissue tumors. The tumor is then staged based on Enneking system for for benign and malignant bone tumors]]. | ||
===Biopsy=== | ===Biopsy=== | ||
*Biopsy is the gold standard test for the diagnosis of chondrosarcoma. <ref>{{cite book | last = Peabody | first = Terrance | title = Orthopaedic oncology : primary and metastatic tumors of the skeletal system | publisher = Springer | location = Cham | year = 2014 | isbn = 9783319073224 }}</ref><ref>{{cite book | last = Czerniak | first = Bogdan | title = Dorfman and Czerniak's bone tumors | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2016 | isbn = 9780323023962 }}</ref> | *[[Biopsy]] is the gold standard test for the diagnosis of chondrosarcoma. <ref>{{cite book | last = Peabody | first = Terrance | title = Orthopaedic oncology : primary and metastatic tumors of the skeletal system | publisher = Springer | location = Cham | year = 2014 | isbn = 9783319073224 }}</ref><ref>{{cite book | last = Czerniak | first = Bogdan | title = Dorfman and Czerniak's bone tumors | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2016 | isbn = 9780323023962 }}</ref> | ||
===Indications=== | ===Indications=== | ||
*Aggressive bone or soft tissue lesions | *Aggressive [[bone]] or [[soft tissue]] lesions. | ||
*Soft tissue lesions more than 5cms | *[[Soft tissue]] lesions more than 5cms. | ||
*Soft tissue lesions deep to fascia | *[[Soft tissue]] lesions deep to [[fascia]]. | ||
*Soft tissue lesions overlying bone | *[[Soft tissue]] lesions overlying [[bone]] or [[Neurovascular bundle|neurovascular]] structures. | ||
*When diagnosis is unclear despite patient being symptomatic | *When diagnosis is unclear despite patient being symptomatic. | ||
*Solitary bone lesions in a patient with history of carcinoma | *Solitary [[bone]] lesions in a patient with history of [[carcinoma]]. | ||
===Contraindications=== | ===Contraindications=== | ||
*Asymptomatic latent bone lesions | *Asymptomatic latent [[bone]] lesions. | ||
*Symptomatic benign active bone lesions confirmed on imaging studies | *Symptomatic [[benign]] active [[bone]] lesions confirmed on [[imaging studies]]. | ||
*Asymptomatic soft tissue lesion which are completely benign on MRI such as lipoma and hemangioma | *Asymptomatic [[soft tissue]] lesion which are completely [[benign]] on [[MRI]] such as [[lipoma]] and [[hemangioma]]. | ||
'''Prerequisites for a Biopsy''' | '''Prerequisites for a Biopsy''' | ||
*CBC, platelets and coagulation studies | *[[Complete blood count|CBC]], [[Platelet|platelets]] and [[coagulation studies]]. | ||
*Cross-sectional imaging to evaluate local anatomy such CT scan and MRI. | *Cross-sectional [[imaging]] to evaluate local [[anatomy]] such [[Computed tomography|CT scan]] and [[Magnetic resonance imaging|MRI]]. | ||
*Treatment center carrying out biopsy must be capable of proper diagnosis and treatment. | *Treatment center carrying out [[biopsy]] must be capable of proper diagnosis and treatment. | ||
*The surgeon who performs biopsy should preferably be the one who is later going to do the final excision. | *The surgeon who performs [[biopsy]] should preferably be the one who is later going to do the final excision. | ||
'''Technique''' | '''Technique''' | ||
| Line 36: | Line 36: | ||
===Open Technique=== | ===Open Technique=== | ||
*The tumor is surgically exposed and | *The tumor is surgically exposed and [[biopsy]] of the [[tumor]] is taken. | ||
{| align="right" | {| align="right" | ||
| | | | ||
| Line 43: | Line 43: | ||
===Types=== | ===Types=== | ||
===Incisional biopsy=== | ===Incisional biopsy=== | ||
*A small surgical incision carefully placed to access tumor without contamination of critical structures | *A small surgical [[incision]] carefully placed to access [[tumor]] without contamination of critical structures. | ||
===Excisional biopsy=== | ===Excisional biopsy=== | ||
*it is done for small, superficial soft tissue masses. | *it is done for small, superficial [[soft tissue]] masses. | ||
'''Incision''' | '''Incision''' | ||
*Longitudinal incision in the extremities is taken. | *Longitudinal [[incision]] in the extremities is taken. | ||
*It should allow for extension of the incision for definitive management | *It should allow for extension of the [[incision]] for definitive management | ||
'''Approach''' | '''Approach''' | ||
*Never expose neurovascular structures. | *Never expose [[Neurovascular bundle|neurovascular]] structures. | ||
*During the biopsy, all tissue exposed is considered contaminated with tumor. | *During the [[biopsy]], all tissue exposed is considered contaminated with [[tumor]]. | ||
*Meticulous hemostasis to be carried out. | *Meticulous [[hemostasis]] to be carried out. | ||
*Post-surgery hematomas are considered contaminated with tumor. | *Post-surgery [[hematomas]] are considered contaminated with [[tumor]]. | ||
*Always deflate the tourniquet prior to wound closure. | *Always deflate the [[tourniquet]] prior to wound closure. | ||
'''Biopsy''' | '''Biopsy''' | ||
*Perform through the involved compartment of the tumor. | *Perform through the involved compartment of the [[tumor]]. | ||
*For bone lesions with a soft tissue mass, perform the biopsy using the soft tissue mass. | *For [[bone]] lesions with a [[soft tissue]] mass, perform the [[biopsy]] using the [[soft tissue]] mass. | ||
'''Closure'' | '''Closure''' | ||
*If drain is kept, remove the drain out of the skin in line with surgical incision. | *If [[Drain (surgery)|drain]] is kept, remove the [[Drain (surgery)|drain]] out of the skin in line with surgical [[incision]]. | ||
*This helps in excising the drain site with definitive surgical | *This helps in excising the [[Drain (surgery)|drain]] site with definitive surgical extensive [[incision]]. | ||
===Closed Technique=== | ===Closed Technique=== | ||
| Line 71: | Line 71: | ||
===Types=== | ===Types=== | ||
===Fine Needle Aspiration (FNA)=== | ===Fine Needle Aspiration (FNA)=== | ||
*It provides cytologic specimen. | *It provides [[Cytological|cytologic]] specimen. | ||
*It is the most commonly used for carcinoma. | *It is the most commonly used for [[carcinoma]]. | ||
*It is usually not preferred for sarcoma. | *It is usually not preferred for [[sarcoma]]. | ||
{| align="right" | {| align="right" | ||
| | | | ||
| Line 79: | Line 79: | ||
|} | |} | ||
===Core biopsy (Tru-cut Biopsy)=== | ===Core biopsy (Tru-cut Biopsy)=== | ||
*It allows for tumor structural examination. | *It allows for [[tumor]] structural examination. | ||
*It allows evaluation of both the cytologic and stromal elements of the tumor. | *It allows evaluation of both the [[Cytological|cytologic]] and [[stromal]] elements of the [[tumor]]. | ||
*It is frequently used for sarcomas. | *It is frequently used for [[Sarcoma|sarcomas]]. | ||
===== Sequence of Diagnostic Studies ===== | ===== Sequence of Diagnostic Studies ===== | ||
The various investigations must be performed in the following order: | The various investigations must be performed in the following order: | ||
*X-ray | *[[X-rays|X-ray]] | ||
*MRI | *[[MRI]] | ||
*Biopsy | *[[Biopsy]] | ||
===Staging=== | ===Staging=== | ||
| Line 109: | Line 109: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | Aggressive: Indistinct borders | | style="padding: 5px 5px; background: #F5F5F5;" | Aggressive: Indistinct borders | ||
|} | |} | ||
*The Enneking surgical staging system (also known as the MSTS system) for malignant [[Musculoskeletal system|musculoskeletal]] [[Tumor|tumors]] based on histological and [[radiographic]] characteristics of the tumor host margin.<ref name="pmid20333492">{{cite journal| author=Jawad MU, Scully SP| title=In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system. | journal=Clin Orthop Relat Res | year= 2010 | volume= 468 | issue= 7 | pages= 2000-2 | pmid=20333492 | doi=10.1007/s11999-010-1315-7 | pmc=2882012 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20333492 }} </ref><ref>{{cite book | last = Peabody | first = Terrance | title = Orthopaedic oncology : primary and metastatic tumors of the skeletal system | publisher = Springer | location = Cham | year = 2014 | isbn = 9783319073224 }}</ref> | *The Enneking surgical staging system (also known as the MSTS system) for malignant [[Musculoskeletal system|musculoskeletal]] [[Tumor|tumors]] based on histological and [[radiographic]] characteristics of the tumor host margin.<ref name="pmid20333492">{{cite journal| author=Jawad MU, Scully SP| title=In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system. | journal=Clin Orthop Relat Res | year= 2010 | volume= 468 | issue= 7 | pages= 2000-2 | pmid=20333492 | doi=10.1007/s11999-010-1315-7 | pmc=2882012 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20333492 }} </ref><ref>{{cite book | last = Peabody | first = Terrance | title = Orthopaedic oncology : primary and metastatic tumors of the skeletal system | publisher = Springer | location = Cham | year = 2014 | isbn = 9783319073224 }}</ref> | ||
Revision as of 18:08, 23 January 2019
[[Biopsy|Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]]]C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Rohan A. Bhimani, M.B.B.S., D.N.B., M.Ch.[3]
Synonyms and keywords: Bone biopsy, Soft tissue biopsy, Biopsy in musculoskeletal system
Overview
Biopsy
Indications
- Aggressive bone or soft tissue lesions.
- Soft tissue lesions more than 5cms.
- Soft tissue lesions deep to fascia.
- Soft tissue lesions overlying bone or neurovascular structures.
- When diagnosis is unclear despite patient being symptomatic.
- Solitary bone lesions in a patient with history of carcinoma.
Contraindications
- Asymptomatic latent bone lesions.
- Symptomatic benign active bone lesions confirmed on imaging studies.
- Asymptomatic soft tissue lesion which are completely benign on MRI such as lipoma and hemangioma.
Prerequisites for a Biopsy
- CBC, platelets and coagulation studies.
- Cross-sectional imaging to evaluate local anatomy such CT scan and MRI.
- Treatment center carrying out biopsy must be capable of proper diagnosis and treatment.
- The surgeon who performs biopsy should preferably be the one who is later going to do the final excision.
Technique
- Open
- Closed
Open Technique
 |
Types
Incisional biopsy
- A small surgical incision carefully placed to access tumor without contamination of critical structures.
Excisional biopsy
- it is done for small, superficial soft tissue masses.
Incision
- Longitudinal incision in the extremities is taken.
- It should allow for extension of the incision for definitive management
Approach
- Never expose neurovascular structures.
- During the biopsy, all tissue exposed is considered contaminated with tumor.
- Meticulous hemostasis to be carried out.
- Post-surgery hematomas are considered contaminated with tumor.
- Always deflate the tourniquet prior to wound closure.
Biopsy
- Perform through the involved compartment of the tumor.
- For bone lesions with a soft tissue mass, perform the biopsy using the soft tissue mass.
Closure
- If drain is kept, remove the drain out of the skin in line with surgical incision.
- This helps in excising the drain site with definitive surgical extensive incision.
Closed Technique
Types
Fine Needle Aspiration (FNA)
- It provides cytologic specimen.
- It is the most commonly used for carcinoma.
- It is usually not preferred for sarcoma.
 |
Core biopsy (Tru-cut Biopsy)
- It allows for tumor structural examination.
- It allows evaluation of both the cytologic and stromal elements of the tumor.
- It is frequently used for sarcomas.
Sequence of Diagnostic Studies
The various investigations must be performed in the following order:
Staging
Enneking (MSTS) Staging System
- The Enneking surgical staging system (also known as the MSTS system) for benign musculoskeletal tumors based on radiographic characteristics of the tumor host margin.[3]
- It is widely accepted and routinely used classification.
| Stages | Description |
|---|---|
| 1 | Latent: Well demarcated borders |
| 2 | Active: Indistinct borders |
| 3 | Aggressive: Indistinct borders |
- The Enneking surgical staging system (also known as the MSTS system) for malignant musculoskeletal tumors based on histological and radiographic characteristics of the tumor host margin.[3][4]
| Stages | Grade | Site | Metastasis |
|---|---|---|---|
| IA | G1: Low grade | T1: Intracompartmental | M0: No metastasis |
| IB | G1: Low grade | T2: Extracompartmental | M0: No metastasis |
| IIA | G2: High grade | T1: Intracompartmental | M0: No metastasis |
| IIB | G2: High grade | T2: Extracompartmental | M0: No metastasis |
| III | G1 or G2 | T1 or T2 | M1: Regional or distant metastasis |
References
- ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.
- ↑ Czerniak, Bogdan (2016). Dorfman and Czerniak's bone tumors. Philadelphia, PA: Elsevier/Saunders. ISBN 9780323023962.
- ↑ 3.0 3.1 Jawad MU, Scully SP (2010). "In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system". Clin Orthop Relat Res. 468 (7): 2000–2. doi:10.1007/s11999-010-1315-7. PMC 2882012. PMID 20333492.
- ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.